首页> 外文期刊>Vaccine >Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge
【24h】

Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge

机译:鼠伤寒沙门氏菌的脂多糖和肠细菌共同抗原的调控延迟合成可增强针对异源沙门氏菌攻击的免疫原性和交叉保护功效

获取原文
获取原文并翻译 | 示例
           

摘要

Lipopolysaccharide (LPS) O-antigen and enterobacterial common antigen (ECA) are two major polysaccharide structures on the surface of Salmonella enterica serovar Typhimurium. Previous studies have demonstrated that regulated truncation of LPS enhances the cross-reaction against conserved outer membrane proteins (OMPs) from enteric bacteria. We speculate that the regulation of both O-antigen and ECA may enhance the induction of immune responses against conserved OMPs from enteric bacteria. In this work we targeted rfbB and rffG genes which encode dTDP-glucose 4,6-dehydratases and share the same function in regulating O-antigen and ECA synthesis. We constructed a mutant, 5496 (Delta rfbB6 Delta rffG7 Delta pagL73::TT araC P-BAD rfbB-3), in which rfbB gene expression was dependent on exogenously supplied arabinose during in vitro growth and achieved the simultaneous tight regulation of both LPS and ECA synthesis, as demonstrated by the LPS profile and Western blotting using antisera against LPS and ECA. When administered orally, S. Typhimurium 5496 was completely attenuated for virulence but still retained the capacity to colonize and disseminate in mice. In addition, we found that oral immunization with S496 resulted in increased immune responses against OMPs from enteric bacteria and enhanced survival compared with immunization with 5492 possessing Delta rfbB6 Delta rffG8 mutations when challenged with lethal doses of Salmonella Choleraesuis or Salmonella Enteritidis. These results indicate that S. Typhimurium arabinose-regulated rfbB strain S496 is a good vaccine candidate, conferring cross-protection against lethal challenge with heterologous Salmonella. Published by Elsevier Ltd.
机译:脂多糖(LPS)O抗原和肠细菌共同抗原(ECA)是肠沙门氏菌血清鼠伤寒沙门氏菌表面的两个主要多糖结构。先前的研究表明,LPS的截短可增强与肠道细菌保守的外膜蛋白(OMP)的交叉反应。我们推测,O-抗原和ECA的调节可能会增强针对肠道细菌保守OMPs的免疫应答的诱导。在这项工作中,我们针对的是编码dTDP-葡萄糖4,6-脱水酶的rfbB和rffG基因,它们在调节O抗原和ECA合成中具有相同的功能。我们构建了一个突变体5496(Delta rfbB6 Delta rffG7 Delta pagL73 :: TT araC P-BAD rfbB-3),其中rfbB基因的表达依赖于体外生长过程中外源提供的阿拉伯糖,并且同时实现了LPS和LPS谱和使用针对LPS和ECA的抗血清进行的Western印迹证实了ECA的合成。口服时,鼠伤寒沙门氏菌5496的毒性完全减弱,但仍保留了在小鼠中定居和传播的能力。此外,我们发现,与具有致死剂量的沙门氏菌霍乱沙门氏菌或肠炎沙门氏菌挑战的5492具有Delta rfbB6 Delta rffG8突变的免疫相比,用S496口服免疫可增强针对肠道细菌对OMPs的免疫反应并提高存活率。这些结果表明,鼠伤寒沙门氏菌阿拉伯糖调节的rfbB菌株S496是很好的候选疫苗,可以交叉保护免受异源沙门氏菌的致死性攻击。由Elsevier Ltd.发布

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号